Latest Blog Posts Tagged "Research News"
March 25, 2015
Paul Cannon, PhD, who leads the 23andMe Parkinson's Community, spoke with MJFF about the company's recent news and what it means for Parkinson's disease drug development.
March 23, 2015
Pharmaceutical company Biogen last week shared positive results from its study of a drug to slow Alzheimer's progression. These findings have implications for Parkinson's research, as well.
March 20, 2015
Irish biotechnology company Prothena announced yesterday that its vaccine in development to slow Parkinson's disease (PD) progression was safe and tolerable in a Phase I study.
March 16, 2015
Our latest podcast covers how researchers are investigating ways to expand the current capabilities of deep brain stimulation.
March 12, 2015
Following Monday's announcement of Apple's ResearchKit and MJFF's Fox Insight online study, news outlets around the web are chiming in about technology's impact on medical research.
March 09, 2015
In conjunction with Apple's announcement of ResearchKit, MJFF is announcing the launch of Fox Insight, a Web-based virtual clinical study open to individuals of any age, both with and without PD.
March 05, 2015
In recent years research into the GBA gene and the GCase protein has expanded, offering another avenue to avoiding or treating Parkinson's disease.
February 11, 2015
Geneticist Dr. Tatiana Foroud explains how the study of Parkinson's genetics can help develop new therapies.
February 04, 2015
The Foundation has united three powerhouse pharmaceutical companies for a pre-competitive consortium to advance LRRK2 inhibitors as potential disease-modifying medications.
January 16, 2015
MJFF funded drug to move into clinical testing after receiving $480 million in follow-on funding.